Patent application number | Description | Published |
20080302272 | NONPOLAR AND SOLID OR PHASE CHANGE INK COMPOSITIONS COMPRISING QUINACRIDONE NANOSCALE PIGMENT PARTICLES - A nonpolar or solid or phase change ink composition which includes a carrier and a nanoscale pigment particle composition, which nanoscale pigment particle composition includes a quinacridone pigment molecules including at least one functional moiety, and a sterically bulky stabilizer compound including at least one functional group, the functional moiety of the pigment associates non-covalently with the functional group of the stabilizer, and the presence of the associated stabilizer limits the extent of particle growth and aggregation, to afford nanoscale-sized particles. | 12-11-2008 |
20100083869 | FLUORESCENT NANOSCALE PARTICLES - A nanoscale pigment particle composition includes a fluorescent compound, such as a benzothioxanthene pigment, including at least one functional moiety, and a stabilizer compound including at least one functional group, wherein the functional moiety associates non-covalently with the functional group; and the presence of the associated stabilizer limits the extent of particle growth and aggregation, to afford nanoscale-sized particles. | 04-08-2010 |
20100086683 | FLUORESCENT SOLID INK MADE WITH FLUORESCENT NANOPARTICLES - A nonpolar or solid (or phase change) ink composition that includes a carrier and at least one nanoscale fluorescent pigment particle composition and/or a fluorescent organic nanoparticle composition. The fluorescent organic nanoparticle composition includes a polymeric matrix obtained by modified EA latex process and/or emulsion polymerization and one or more fluorescent dyes and the nanoscale fluorescent pigment particle composition includes pigment molecules with at least one functional moiety, and a sterically bulky stabilizer compound including at least one functional group, the functional moiety of the pigment associates non-covalently with the functional group of the stabilizer. | 04-08-2010 |
20100086701 | RADIATION CURABLE INK CONTAINING FLUORESCENT NANOPARTICLES - Radiation curable compositions, such as UV curable ink compositions, contain a polymeric dispersant, a curable material, that includes a carrier and at least one nanoscale fluorescent pigment particle and an optional non-fluorescent colorant. The fluorescent organic nanoparticle composition includes one or more fluorescent dyes dispersed in a polymeric matrix obtained by modified EA latex process or by emulsion polymerization. In a different embodiment, the nanoscale fluorescent pigment particle composition includes pigment molecules with at least one functional moiety, and a sterically bulky stabilizer compound including at least one functional group, the functional moiety of the pigment associates non-covalently with the functional group of the stabilizer, and the presence of the associated stabilizer limits the extent of particle growth and aggregation, to afford nanoscale-sized pigment particles. | 04-08-2010 |
20100086867 | TONER CONTAINING FLUORESCENT NANOPARTICLES - A method for making toners to include at least one nanoscale fluorescent pigment particle composition and/or a fluorescent organic nanoparticle composition. The particles are incorporated into emulsion of toner and used in making toner via emulsion aggregation. Such toners may have a core and/or a shell and the clay composites may be included within the core, the shell or both. The fluorescent organic nanoparticle composition includes a polymeric matrix obtained by modified EA latex process and/or emulsion polymerization and one or more fluorescent dyes and the nanoscale fluorescent pigment particle composition includes pigment molecules with at least one functional moiety, and a sterically bulky stabilizer compound including at least one functional group, the functional moiety of the pigment associates non-covalently with the functional group of the stabilizer, and the presence of the associated stabilizer limits the extent of particle growth and aggregation, to afford nanoscale-sized pigment particles. | 04-08-2010 |
20110265687 | FLUORESCENT INK COMPOSITIONS AND FLUORESCENT PARTICLES - A fluorescent solid ink, and a method for making such ink, including an ink vehicle and a fluorescent particle. The fluorescent particle includes a fluorescent pigment, such as a trans-dicarboxylic-indenofluorenone, and at least one stabilizing wax chemically attached to the fluorescent pigment. The stabilizing wax includes an amine group at its terminal end and the fluorescent pigment includes at least one carboxylic acid group, where the amine group reacts with the carboxylic acid group to form an amide bond. | 11-03-2011 |
20110269065 | FLUORESCENT TONER COMPOSITIONS AND FLUORESCENT PIGMENTS - A fluorescent particle includes a fluorescent pigment, such as a trans-dicarboxylic-indenofluorenone, and at least one stabilizing wax chemically attached to the fluorescent pigment. The stabilizing wax includes an amine group at its terminal end and the fluorescent pigment includes at least one carboxylic acid group, where the amine group reacts with the carboxylic acid group to form an amide bond. A method for making fluorescent particles for use in toners by chemically attaching at least one stabilizing wax to a fluorescent pigment where the at least one stabilizing wax includes an amine group at its terminal end and the fluorescent pigment includes at least one carboxylic acid group. A toner may include a resin and the fluorescent particle. | 11-03-2011 |
20140073723 | Phase Change Ink with Compostable Wax - Disclosed is a phase change ink comprising: (a) an ink carrier comprising a compostable paraffin or polymethylene wax; and (b) a colorant. | 03-13-2014 |
20140144348 | Phase Change Inks Containing Quinacridone Pigments and Synergists - Disclosed is a phase change ink comprising (i) an ink carrier; (ii) a quinacridone pigment; (iii) a synergist of the formula | 05-29-2014 |
Patent application number | Description | Published |
20090149635 | ANTIBODIES TO HUMAN ZCYTOR17 LIGAND - The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 06-11-2009 |
20090192292 | MURINE ZCYTOR17 LIGAND POLYPEPTIDES AND POLYNUCLEOTIDES - The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 07-30-2009 |
20090274694 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 11-05-2009 |
20100055101 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 03-04-2010 |
20100266499 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 10-21-2010 |
20100266597 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 10-21-2010 |
20110196128 | MURINE ZCYTOR17 LIGAND POLYNUCLEOTIDES - The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 08-11-2011 |
20110318354 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 12-29-2011 |
20120264168 | ZCYTOR17 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 10-18-2012 |
20130143265 | ZCYTOR17 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 06-06-2013 |
20130156695 | USE OF ZCYTOR17 LIGAND ANTAGONISTS FOR TREATING INFLAMMATORY DISEASES - The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 06-20-2013 |
20140141485 | ZCYTOR17 HETERODIMERIC CYTOKINE RECEPTOR - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17-containing multimeric or heterodimer cytokine receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. The present invention also includes methods for producing the multimeric or heterodimeric cytokine receptor, uses therefor and antibodies thereto. | 05-22-2014 |
Patent application number | Description | Published |
20110078714 | SYSTEM AND METHOD OF SHARING VIDEO ON DEMAND CONTENT - A system for and method of sharing Video on Demand content is presented. The system and method may facilitate sharing of Video on Demand (“VOD”) content between friends and family. The sharing of VOD content between users may allow for the users to view the content in a more cost-effective manner than if the VOD content was purchased individually by all the users. Further, giving users the ability to share VOD content between one another may result in more overall viewing of the content. | 03-31-2011 |
20130196720 | MOBILE BATTERY PARTITIONING SYSTEM AND METHOD - A device is configured to receive a request for two or more battery partitions; create the two or more battery partitions according to the received request, where each of the two or more battery partitions relate to a respective function of the device; calculate usage of the two or more battery partitions; present information regarding the usage of the two or more battery partitions; receive a request to change an allotment of at least one of the two or more battery partitions; and re-partition two or more battery partitions according to the received request to change of the allotment of the at least one of the two or more battery partitions. Additionally, the device can be configured to charge one or more battery partitions in an order of priority, re-assign one or more battery partitions to a different area, and provide notifications of usage. | 08-01-2013 |
20140010405 | METHODS AND SYSTEMS FOR CREATING VIRTUAL TRIPS FROM SETS OF USER CONTENT ITEMS - A set of user content items, such as a set of photographs or audio or video recordings, is used to identify recommended locations. Each item of user content in the set includes a geographical identifier and a time-stamp indicative of the location and time of origin of the item. The items of user content are placed in time-order, and a route is determined that links, in time-order, the locations identified by the geographical identifiers. A recommended location is then identified, from a database of recommended locations, that is located near the determined route but is not geographically coincident with the locations of any of the items of user content. Information for a map containing the route and an illustration of the identified location are sent to a terminal device for presentation to a user. | 01-09-2014 |
20140082514 | AUTOMATIC ADJUSTMENT OF SELECTABLE FUNCTION PRESENTATION ON ELECTRONIC DEVICE DISPLAY - An interface controller may control the way a function is presented for selection by a user interface in an electronic device. The interface controller may include a usage detection system configured to detect the way in which the electronic device is being or has been used. The interface controller may also include a presentation controller configured to automatically change the way in which the function is presented for selection by the user interface based on the way in which the usage detection system detects the electronic device is being or has been used. | 03-20-2014 |
20140173051 | INTELLIGENT STREAMING TO A MOBILE DEVICE - Intelligent streaming of multimedia content is provided. Based on various conditions and signals detected by a mobile device, an activity state of the mobile device that indicates whether viewing of a video portion of streaming multimedia content is desirable or likely may be determined. A server streaming the multimedia content, upon receiving from the mobile device either a request to eliminate the video portion streaming multimedia content or a status update that the video portion is not viewable or is not likely being viewed, is configured to replace streaming of the multimedia content with both audio and video portions with streaming of the multimedia content containing the audio portion but without the video portion. | 06-19-2014 |
20140370891 | PROXIMATE DEVICE LOCATOR - A user interested in a networked station, such as a mobile station of a particular type, can obtain information to enable the user to locate and/or contact another person with a station of the particular type, e.g. at a location within a set distance from or in proximity to the current location of the user's station. Alternatively, the user of the requesting networked station may provide identities of members of a social media network; and the system can then identify the members who are users of the particular networked station. In either case, the user of the requesting networked station can use the received information to obtain a first-hand review of the particular networked station or to contact another user to request a meeting to view of operate the particular station. | 12-18-2014 |
20150121225 | Method and System for Navigating Video to an Instant Time - A system and method are presented for navigating through image frames of video content to display particular frames of the video content while the video content continues to play. The system provides a viewer the ability to interact with and operate a device playing video content using touch input or input from a peripheral device to permit locating and displaying particular frames of video content concurrently with ongoing display of the video content. | 04-30-2015 |